Analyst price target range
Humacyte Price Target: $1.85 Average
HUMA target range is $1.00 to $4.00. As of 2026-08-24.
Direct answer
Humacyte's average price target is $1.85.
The verified analyst range runs from $1.00 to $4.00.
The low target implies +50.7%, the high target implies +502.8%, and the range spans 452.1% of the current price.
Forecast evidence checked August 24, 2026.
Get free Humacyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.66
- Average price target
- $1.85
- High price target
- $4.00
- Low price target
- $1.00
- Low target gap
- +50.7%
- Target upside
- +178.8%
- High target gap
- +502.8%
- Target range width
- 452.1%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is Humacyte's average price target?
Humacyte's verified average price target is $1.85. The target range is $1.00 to $4.00.
How far are Humacyte's low and high targets from the recorded price?
The low target implies +50.7%, while the high target implies +502.8%.
How many analysts are included in Humacyte's consensus?
The verified consensus includes 5 analysts.
How is Humacyte's target upside or downside calculated?
The average target of $1.85 is divided by the recorded price of $0.66, then one is subtracted to produce +178.8%. This does not guarantee a future return.
When was Humacyte's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.